Comparing Polyglactin vs Polypropylene Sutures for Rectus Sheath Closure

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorLady Reading Hospital, Pakistan

About this trial

This randomized controlled trial aims to compare the outcomes of Polyglactin (Vicryl) versus Polypropylene (Prolene) sutures for rectus sheath closure in patients undergoing midline laparotomy. The study will evaluate the rates of incisional hernia, surgical site infection (SSI), wound dehiscence, chronic pain, and suture sinus formation. Participants aged 18-70 years, undergoing either elective or emergency laparotomy, will be randomly assigned to receive either Polyglactin or Polypropylene sutures. The primary outcome measure is the incidence of incisional hernia at 6 months, with secondary outcomes including SSI, wound complications, and chronic pain. The study is particularly important in the context of Pakistan, where such comparative data is limited, and aims to provide evidence-based recommendations for optimal suture material selection in general surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age: 18-70 years.

Type of Surgery: Patients undergoing elective or emergency midline laparotomy.

Wound Classification: Clean or clean-contaminated wounds (CDC Class I or II).

Ability to Provide Informed Consent: Participants must be able to understand and sign the informed consent form.

Disqualifiers

Contaminated or Dirty Wounds: Patients with CDC Class III or IV wounds.

Immunocompromised Conditions: Patients on steroids, chemotherapy, or those with HIV.

Previous Midline Laparotomy with Incisional Hernia: Patients who have a history of incisional hernia after midline laparotomy.

Severe Malnutrition: Patients with BMI < 16 kg/m² or albumin < 2.5 g/dL.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Polyglactin 910 (Vicryl) Suture

    Procedure/Surgery

    Polyglactin 910 (Vicryl) is an absorbable synthetic multifilament suture material used for rectus sheath closure following laparotomy. This suture material undergoes hydrolytic degradation over a period of 56-70 days and retains approximately 75% of its tensile strength at 2 weeks and 50% at 3 weeks, which aligns with the typical biological timeline for fascial healing. It is used to approximate the anterior rectus sheath with a continuous suturing technique.

  • Polypropylene (Prolene) Suture

    Procedure/Surgery

    Polypropylene (Prolene) is a non-absorbable monofilament suture material used for rectus sheath closure following laparotomy. It provides long-term mechanical support for abdominal wall closure and does not degrade over time. The suture material maintains its tensile strength indefinitely and is known for its high biocompatibility, minimal tissue reaction, and resistance to infection due to its monofilament structure. It is applied using a continuous suturing technique.

Treatment groups

156 Participants
are divided into 2 treatment groups
Group A: Polyglactin 910 (Vicryl) Suture for Rectus Sheath ClosureExperimental treatment 1 intervention
Group B: Polypropylene (Prolene) Suture for Rectus Sheath ClosureActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Incisional Hernia rate

The primary outcome will assess the rate of incisional hernia at 6 months post-surgery in patients who undergo rectus sheath closure with either Polyglactin 910 (Vicryl) or Polypropylene (Prolene) sutures.

Time frame
6 months postoperatively

Secondary outcomes

1

Surgical Site Infection (SSI) Rate

This outcome will measure the occurrence of any surgical site infection (SSI) within 30 days postoperatively.

Time frame
30 days post-surgery
2

Suture Sinus Formation

The occurrence of chronic draining tracts at the incision site, which are associated with the suture material.

Time frame
6 months post-surgery
3

Chronic Pain (Visual Analog Scale, VAS ≥4)

The presence of chronic pain at the surgical site lasting more than 3 months postoperatively, assessed using the Visual Analog Scale (VAS), where the VAS is a 10-point scale ranging from 0 (no pain) to 10 (worst possible pain). A score of 4 or higher indicates the presence of clinically significant chronic pain.

Time frame
3 months post-surgery
4

Wound Dehiscence

The occurrence of wound dehiscence, defined as partial or complete disruption of the rectus sheath, within 30 days post-surgery.

Time frame
30 days post-surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: